BNS Stock Analysis: Bank of Nova Scotia | NYSE
Banks - Diversified | NYSE, USA | Market Cap: 112.413m USD | 12M Return: 46.5% | CA0641491075 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 154M
EPS Trend: 72.5%
Qual. Beats: 0
Rev. Trend: 82.3%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Bank of Nova Scotia (BNS) is a Canadian-headquartered diversified bank operating across four reportable segments: Canadian Banking, International Banking, Global Wealth Management, and Global Banking and Markets. Its service footprint spans Canada, the United States, Mexico, Peru, Chile, Colombia, the Caribbean, and Central America, as well as other international markets. Founded in 1832 and listed on the NYSE since 1999, BNS is classified as a Large Cap stock within the GICS Diversified Banks sub-industry, with a market capitalization of approximately $114.5 billion USD.
On the retail side, the company offers financial advice and solutions to individuals, including debit and credit cards, chequing and savings accounts, investments, mortgages, loans, insurance, and retail automotive financing. It also serves small, medium, and large businesses with lending, deposit, cash management, and trade finance solutions, with trade finance typically involving the facilitation of cross-border commercial transactions through letters of credit, guarantees, and related instruments.
In wealth management, BNS provides online and full-service brokerage, mobile investing, trust, private banking, and private investment counsel services, along with retail mutual funds, exchange-traded funds, liquid alternatives, and institutional funds. As part of the broader Diversified Banks sub-industry, the company competes alongside other globally active Canadian banks that combine retail, commercial, wealth, and capital markets operations under a single corporate structure.
- Mexican peso weakness pressures International Banking earnings translation
- Canadian mortgage growth slows amid housing market uncertainty
- Latin America credit losses rise on Peru Chile economic stress
| Net Income: 10.0b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 1.05 > 1.0 |
| NWC/Revenue: -316.7% < 20% (prev -1.12k%; Δ 808.0% < -1%) |
| CFO/TA 0.00 > 3% & CFO 6.96b > Net Income 10.0b |
| Net Debt (265b) to EBITDA (15.0b): 17.73 < 3 |
| Current Ratio: 0.04 > 1.5 & < 3 |
| Outstanding Shares: last quarter (874.0m) vs 12m ago -29.80% < -2% |
| Gross Margin: 48.67% > 18% (prev 42.48%; Δ 6.20% > 0.5%) |
| Asset Turnover: 4.83% > 50% (prev 5.22%; Δ -0.40% > 0%) |
| Interest Coverage Ratio: 0.42 > 6 (EBIT TTM 13.4b / Interest Expense TTM 32.1b) |
| A: -0.15 (Total Current Assets 10.3b - Total Current Liabilities 237b) / Total Assets 1549b |
| B: 0.04 (Retained Earnings 60.4b / Total Assets 1549b) |
| C: 0.01 (EBIT TTM 13.4b / Avg Total Assets 1482b) |
| D: 0.06 (Book Value of Equity 89.2b / Total Liabilities 1458b) |
| Altman-Z'' = -0.71 = B |
As of October 03, 2026, the stock is trading at USD 91.19 with a total of 1,007,281 shares traded. Over the past week, the price has changed by -2.45%, over one month by -2.27%, over three months by +7.80% and over the past year by +46.46%.
Current recommended Stop Loss: 87.00 (which is 4.6% or 2.7 ATR below the current price).
Bank of Nova Scotia has received a consensus analysts rating of 3.47. Therefore, it is recommended to hold BNS.
- StrongBuy: 4
- Buy: 0
- Hold: 10
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 90.4 | -0.9% |
Market Cap CAD = 160b (112b USD * 1.4247 USD.CAD)
P/E Trailing = 16.954
P/E Forward = 13.8313
P/S = 3.1879
P/B = 2.0222
P/EG = 0.9958
Revenue TTM = 71.5b CAD
EBIT TTM = 13.4b CAD
EBITDA TTM = 15.0b CAD
Long Term Debt = 217b CAD (from longTermDebt, last quarter)
Short Term Debt = 237b CAD (from shortTermDebt, last quarter)
Debt = 276b CAD (from shortLongTermDebtTotal, last quarter) + Leases 2.96b
Net Debt = 265b CAD (calculated: Debt 276b - CCE 10.3b)
Enterprise Value = 425b CAD (160b + Debt 276b - CCE 10.3b)
Interest Coverage Ratio = 0.42 (Ebit TTM 13.4b / Interest Expense TTM 32.1b)
EV/FCF = 11.65x (Enterprise Value 425b / FCF TTM 36.5b)
FCF Yield = 8.58% (FCF TTM 36.5b / Enterprise Value 425b)
FCF Margin = 51.06% (FCF TTM 36.5b / Revenue TTM 71.5b)
Net Margin = 14.00% (Net Income TTM 10.0b / Revenue TTM 71.5b)
Gross Margin = 48.67% ((Revenue TTM 71.5b - Cost of Revenue TTM 36.7b) / Revenue TTM)
Gross Margin QoQ = 49.98% (prev 48.86%)
Tobins Q-Ratio = 0.27 (Enterprise Value 425b / Total Assets 1549b)
Interest Expense / Debt = 11.66% (Interest Expense 32.1b / Debt 276b)
Taxrate = 24.92% (3.28b / 13.2b)
NOPAT = 10.0b (EBIT 13.4b * (1 - 24.92%))
Current Ratio = 0.04 (Total Current Assets 10.3b / Total Current Liabilities 237b)
Debt / Equity = 3.09 (Debt 276b / totalStockholderEquity, last quarter 89.2b)
Debt / EBITDA = 17.73 (Net Debt 265b / EBITDA 15.0b)
Debt / FCF = 7.26 (Net Debt 265b / FCF TTM 36.5b)
Total Stockholder Equity = 87.7b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.68% (Net Income 10.0b / Total Assets 1549b)
RoE = 11.41% (Net Income TTM 10.0b / Total Stockholder Equity 87.7b)
RoCE = 4.39% (EBIT 13.4b / Capital Employed (Equity 87.7b + L.T.Debt 217b))
RoIC = 0.65% (NOPAT 10.0b / Invested Capital 1545b)
WACC = 8.53% (E(160b)/V(436b) * Re(8.16%) + D(276b)/V(436b) * Rd(11.66%) * (1-Tc(0.25)))
Discount Rate = 8.16% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -67.46 | Cagr: -14.03%
[DCF] Terminal Value 77.38% ; FCFF base≈29.3b ; Y1≈33.6b ; Y5≈49.4b
[DCF] Fair Price = 373.5 (EV 720b - Net Debt 265b = Equity 455b / Shares 1.22b; r=8.53% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 72.47 | EPS CAGR: 6.19% | SUE: 0.66 | # QB: 0
Revenue Correlation: 82.25 | Revenue CAGR: 35.09% | SUE: 0.76 | # QB: 0
EPS current Quarter (2027-01-31): EPS=2.32 | Chg30d=+3.11% | Revisions=+38% | Analysts=7
EPS current Year (2026-10-31): EPS=8.53 | Chg30d=+2.90% | Revisions=+80% | GrowthEPS=+20.3% | GrowthRev=+7.6%
EPS next Year (2027-10-31): EPS=9.49 | Chg30d=+2.43% | Revisions=+67% | GrowthEPS=+11.3% | GrowthRev=+5.1%
[Analyst] Revisions Ratio: +78% (up=27, down=2)